Literature DB >> 30053426

Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.

Leah V Sibener1, Ricardo A Fernandes2, Elizabeth M Kolawole3, Catherine B Carbone4, Fan Liu5, Darren McAffee6, Michael E Birnbaum1, Xinbo Yang2, Laura F Su7, Wong Yu7, Shen Dong2, Marvin H Gee1, Kevin M Jude2, Mark M Davis8, Jay T Groves6, William A Goddard9, James R Heath10, Brian D Evavold3, Ronald D Vale11, K Christopher Garcia12.   

Abstract

TCR-signaling strength generally correlates with peptide-MHC binding affinity; however, exceptions exist. We find high-affinity, yet non-stimulatory, interactions occur with high frequency in the human T cell repertoire. Here, we studied human TCRs that are refractory to activation by pMHC ligands despite robust binding. Analysis of 3D affinity, 2D dwell time, and crystal structures of stimulatory versus non-stimulatory TCR-pMHC interactions failed to account for their different signaling outcomes. Using yeast pMHC display, we identified peptide agonists of a formerly non-responsive TCR. Single-molecule force measurements demonstrated the emergence of catch bonds in the activating TCR-pMHC interactions, correlating with exclusion of CD45 from the TCR-APC contact site. Molecular dynamics simulations of TCR-pMHC disengagement distinguished agonist from non-agonist ligands based on the acquisition of catch bonds within the TCR-pMHC interface. The isolation of catch bonds as a parameter mediating the coupling of TCR binding and signaling has important implications for TCR and antigen engineering for immunotherapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD45; MHC; TCR; catch bond; ligand discrimination; molecular dynamics; signaling; structure

Mesh:

Substances:

Year:  2018        PMID: 30053426      PMCID: PMC6140336          DOI: 10.1016/j.cell.2018.06.017

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  70 in total

1.  Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.

Authors:  V Rubio-Godoy; V Dutoit; D Rimoldi; D Lienard; F Lejeune; D Speiser; P Guillaume; J C Cerottini; P Romero; D Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.

Authors:  Wong Yu; Ning Jiang; Peter J R Ebert; Brian A Kidd; Sabina Müller; Peder J Lund; Jeremy Juang; Keishi Adachi; Tiffany Tse; Michael E Birnbaum; Evan W Newell; Darrell M Wilson; Gijsbert M Grotenbreg; Salvatore Valitutti; Stephen R Quake; Mark M Davis
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

3.  T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.

Authors:  Dennis X Beringer; Fleur S Kleijwegt; Florian Wiede; Arno R van der Slik; Khai Lee Loh; Jan Petersen; Nadine L Dudek; Gaby Duinkerken; Sandra Laban; Antoinette Joosten; Julian P Vivian; Zhenjun Chen; Adam P Uldrich; Dale I Godfrey; James McCluskey; David A Price; Kristen J Radford; Anthony W Purcell; Tatjana Nikolic; Hugh H Reid; Tony Tiganis; Bart O Roep; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

4.  Size-dependent protein segregation at membrane interfaces.

Authors:  Eva M Schmid; Matthew H Bakalar; Kaushik Choudhuri; Julian Weichsel; HyoungSook Ann; Phillip L Geissler; Michael L Dustin; Daniel A Fletcher
Journal:  Nat Phys       Date:  2016-03-07       Impact factor: 20.034

5.  TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.

Authors:  William F Hawse; Soumya De; Alex I Greenwood; Linda K Nicholson; Jaroslav Zajicek; Evgenii L Kovrigin; David M Kranz; K Christopher Garcia; Brian M Baker
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

6.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.

Authors:  A Bertoletti; A Sette; F V Chisari; A Penna; M Levrero; M De Carli; F Fiaccadori; C Ferrari
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

7.  Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells.

Authors:  Karmel A Allison; Eniko Sajti; Jana G Collier; David Gosselin; Ty Dale Troutman; Erica L Stone; Stephen M Hedrick; Christopher K Glass
Journal:  Elife       Date:  2016-07-04       Impact factor: 8.140

8.  Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation.

Authors:  Michelle Krogsgaard; Nelida Prado; Erin J Adams; Xiao-lin He; Dar-Chone Chow; Darcy B Wilson; K Christopher Garcia; Mark M Davis
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

9.  TCR/pMHC Optimized Protein crystallization Screen.

Authors:  Anna M Bulek; Florian Madura; Anna Fuller; Christopher J Holland; Andrea J A Schauenburg; Andrew K Sewell; Pierre J Rizkallah; David K Cole
Journal:  J Immunol Methods       Date:  2012-06-15       Impact factor: 2.303

10.  In vitro reconstitution of T cell receptor-mediated segregation of the CD45 phosphatase.

Authors:  Catherine B Carbone; Nadja Kern; Ricardo A Fernandes; Enfu Hui; Xiaolei Su; K Christopher Garcia; Ronald D Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-17       Impact factor: 11.205

View more
  101 in total

Review 1.  Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved.

Authors:  Edward F Fritsch; Ute E Burkhardt; Nir Hacohen; Catherine J Wu
Journal:  Cancer Immunol Res       Date:  2020-12       Impact factor: 11.151

2.  DNA probes that store mechanical information reveal transient piconewton forces applied by T cells.

Authors:  Rong Ma; Anna V Kellner; Victor Pui-Yan Ma; Hanquan Su; Brendan R Deal; Joshua M Brockman; Khalid Salaita
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-07       Impact factor: 11.205

Review 3.  Membrane Organization and Physical Regulation of Lymphocyte Antigen Receptors: A Biophysicist's Perspective.

Authors:  Laurent Limozin; Pierre-Henri Puech
Journal:  J Membr Biol       Date:  2019-07-27       Impact factor: 1.843

4.  How drag sharpens a T cell's view on antigen.

Authors:  Gerhard J Schütz; Johannes B Huppa
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

5.  TCR-pMHC kinetics under force in a cell-free system show no intrinsic catch bond, but a minimal encounter duration before binding.

Authors:  Laurent Limozin; Marcus Bridge; Pierre Bongrand; Omer Dushek; Philip Anton van der Merwe; Philippe Robert
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-17       Impact factor: 11.205

6.  Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition.

Authors:  Peng Wu; Tongtong Zhang; Baoyu Liu; Panyu Fei; Lei Cui; Rui Qin; Huaying Zhu; Danmei Yao; Ryan J Martinez; Wei Hu; Chenyi An; Yong Zhang; Junwei Liu; Jiawei Shi; Juan Fan; Weiwei Yin; Jie Sun; Chun Zhou; Xun Zeng; Chenqi Xu; Jianan Wang; Brian D Evavold; Cheng Zhu; Wei Chen; Jizhong Lou
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

7.  Weaponizing T-cell receptors through molecular engineering.

Authors:  Elissa K Leonard; Michael I Leff; Jamie B Spangler
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

Review 8.  Understanding the mechanistic basis of non-coding RNA through molecular dynamics simulations.

Authors:  Giulia Palermo; Lorenzo Casalino; Alessandra Magistrato; J Andrew McCammon
Journal:  J Struct Biol       Date:  2019-03-15       Impact factor: 2.867

Review 9.  Tensile and compressive force regulation on cell mechanosensing.

Authors:  Yunfeng Chen; Zhiyong Li; Lining Arnold Ju
Journal:  Biophys Rev       Date:  2019-05-09

10.  Single-molecule investigations of T-cell activation.

Authors:  Li Kaitao; Rittase William; Yuan Zhou; Zhu Cheng
Journal:  Curr Opin Biomed Eng       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.